Scopolamine
(STECJAGHUSJQJN-OYVHKFOJSA-N)
Structure
- SMILES
- OCC(c1ccccc1)C(=O)OC1C[C@@H]2N([C@@H](C1)[C@H]1[C@@H]2O1)C
- Molecular Formula:
- C17H21NO4
- Molecular Weight:
- 303.353
- Log P:
- 0.8560
- Hydrogen Bond Acceptor:
- 5
- Hydrogen Bond Donor:
- 1
- TPSA:
- 62.3
- CAS Number(s):
- N/A
Synonym(s)
1.
Scopolamine
2.
Hyoscine
3.
Scopolamine Hydrobromide
4.
Boro-Scopol
5.
Isopto Hyoscine
6.
Kwells
7.
Scoburen
8.
Scopace
9.
Scopoderm TTS
10.
Scopolamine Cooper
11.
Transderm Scop
12.
Transderm-V
13.
Travacalm HO
14.
Vorigeno
15.
Boro Scopol
16.
Transderm V
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Incorrect drug administration duration | FAERS: 1 | US FAERS | |
| 2 | Accidental exposure to product | Canada Vigilance: 1 | Canada Vigilance | |
| 3 | Agitation | Canada Vigilance: 1 | Canada Vigilance | |
| 4 | Amnesia | Canada Vigilance: 2 | Canada Vigilance | |
| 5 | Anxiety | Canada Vigilance: 1 | Canada Vigilance | |
| 6 | Application site erythema | Canada Vigilance: 1 | Canada Vigilance | |
| 7 | Application site irritation | Canada Vigilance: 1 | Canada Vigilance | |
| 8 | Application site pruritus | Canada Vigilance: 1 | Canada Vigilance | |
| 9 | Application site rash | Canada Vigilance: 1 | Canada Vigilance | |
| 10 | Application site reaction | Canada Vigilance: 6 | Canada Vigilance | |
| 11 | Application site swelling | Canada Vigilance: 1 | Canada Vigilance | |
| 12 | Asthenia | Canada Vigilance: 2 | Canada Vigilance | |
| 13 | Ataxia | Canada Vigilance: 1 | Canada Vigilance | |
| 14 | Bedridden | Canada Vigilance: 1 | Canada Vigilance | |
| 15 | Blindness | Canada Vigilance: 1 | Canada Vigilance | |
| 16 | Chest Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 17 | Chest discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 18 | Chills | Canada Vigilance: 1 | Canada Vigilance | |
| 19 | Dehydration | Canada Vigilance: 1 | Canada Vigilance | |
| 20 | Dementia | Canada Vigilance: 1 | Canada Vigilance | |
| 21 | Dermatitis | Canada Vigilance: 1 | Canada Vigilance | |
| 22 | Diplopia | Canada Vigilance: 2 | Canada Vigilance | |
| 23 | Disorientation | Canada Vigilance: 4 | Canada Vigilance | |
| 24 | Dizziness | Canada Vigilance: 16 | Canada Vigilance | |
| 25 | Drug ineffective | Canada Vigilance: 3 | Canada Vigilance | |
| 26 | Erythema | Canada Vigilance: 2 | Canada Vigilance | |
| 27 | Eye pain | Canada Vigilance: 1 | Canada Vigilance | |
| 28 | Feeling abnormal | Canada Vigilance: 3 | Canada Vigilance | |
| 29 | Glaucoma | Canada Vigilance: 1 | Canada Vigilance | |
| 30 | Headache | Canada Vigilance: 9 | Canada Vigilance | |
| 31 | Hypersensitivity | Canada Vigilance: 1 | Canada Vigilance | |
| 32 | Hypokinesia | Canada Vigilance: 1 | Canada Vigilance | |
| 33 | Incorrect product administration duration | Canada Vigilance: 1 | Canada Vigilance | |
| 34 | Influenza | Canada Vigilance: 1 | Canada Vigilance | |
| 35 | Intraocular pressure test abnormal | Canada Vigilance: 1 | Canada Vigilance | |
| 36 | Lethargy | Canada Vigilance: 2 | Canada Vigilance | |
| 37 | Malaise | Canada Vigilance: 5 | Canada Vigilance | |
| 38 | Memory impairment | Canada Vigilance: 2 | Canada Vigilance | |
| 39 | Mydriasis | Canada Vigilance: 16 | Canada Vigilance | |
| 40 | Nausea | Canada Vigilance: 14 | Canada Vigilance | |
| 41 | Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 42 | Pharyngitis | Canada Vigilance: 1 | Canada Vigilance | |
| 43 | Photophobia | Canada Vigilance: 3 | Canada Vigilance | |
| 44 | Somnolence | Canada Vigilance: 1 | Canada Vigilance | |
| 45 | Tachycardia | Canada Vigilance: 2 | Canada Vigilance | |
| 46 | Torticollis | Canada Vigilance: 1 | Canada Vigilance | |
| 47 | Tremor | Canada Vigilance: 1 | Canada Vigilance | |
| 48 | Vertigo | Canada Vigilance: 3 | Canada Vigilance | |
| 49 | Visual Impairment | Canada Vigilance: 3 | Canada Vigilance | |
| 50 | Vomiting | Canada Vigilance: 9 | Canada Vigilance | |
| 51 | Weight decreased | Canada Vigilance: 1 | Canada Vigilance | |
| 52 | Wrong technique in product usage process | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.